SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline. Li S, Vandvik PO, Lytvyn L, Guyatt GH, et al. BMJ 2021;373:n1091.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li S, Vandvik PO, Lytvyn L, Guyatt GH, et al. SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline. BMJ 2021;373:n1091.
PMID: 33975892